Fig. 3From: Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safetyHeterogeneity of mosquito mortality according to the ivermectin plasma concentration at the time of biting. LC50 and LC25 according to Kobylinski et al. [46]. The LC95 and LC75 shown have not been determined and are shown for illustration purposes. LC lethal concentrationBack to article page